Canada markets closed

Acurx Pharmaceuticals, Inc. (ACXP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.0100-0.1200 (-5.63%)
At close: 04:00PM EDT
1.9300 -0.08 (-3.98%)
After hours: 07:49PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 32.14M
Enterprise Value 24.67M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.56
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.69

Trading Information

Stock Price History

Beta (5Y Monthly) -1.90
52-Week Change 3-37.77%
S&P500 52-Week Change 320.07%
52 Week High 38.8200
52 Week Low 31.1700
50-Day Moving Average 32.5136
200-Day Moving Average 32.9016

Share Statistics

Avg Vol (3 month) 3108.48k
Avg Vol (10 day) 3111.98k
Shares Outstanding 515.76M
Implied Shares Outstanding 615.76M
Float 813.35M
% Held by Insiders 115.26%
% Held by Institutions 111.63%
Shares Short (Mar 28, 2024) 4337.41k
Short Ratio (Mar 28, 2024) 43.96
Short % of Float (Mar 28, 2024) 42.53%
Short % of Shares Outstanding (Mar 28, 2024) 42.14%
Shares Short (prior month Feb 29, 2024) 4291.93k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-106.65%
Return on Equity (ttm)-243.33%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-14.58M
Diluted EPS (ttm)-1.1500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.47M
Total Cash Per Share (mrq)0.47
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.53
Book Value Per Share (mrq)0.32

Cash Flow Statement

Operating Cash Flow (ttm)-9.8M
Levered Free Cash Flow (ttm)-4.33M